This low specificity is due to the fact that PSA is also increased by benign prostate conditions (e.g., BPH and prostatitis) and poses a risk of unnecessary biopsies to rule out eventual malignancy [9,10]. This evidence concerns the gene KLK3 and benign prostatic hyperplasia.